Stockreport

Regeneron: Fairly Valued Now After A Stellar Upswing [Seeking Alpha]

Regeneron Pharmaceuticals, Inc.  (REGN) 
Last regeneron pharmaceuticals, inc. earnings: 2/6 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: investor.regeneron.com
PDF Declining Eylea/Eylea HD revenues are largely offset by strong Dupixent growth, with Dupixent likely to exceed 50% of total revenue by 2027. Libtayo and pipeline asse [Read more]